Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 5, 2023
- Accession no.
- 0001415889-23-000548
- Filed
- Jan 5, 2023
- Trade date
- Jan 3-4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −3,569 | $273.04F2 | −$974,479.76 | 4,561 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −2,253 | $273.68F3 | −$616,601.04 | 2,308 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −2,033 | $274.82F4 | −$558,709.06 | 275 | Direct | |
| Jan 3, 2023 | Common Stock | SSaleDisposed | −145 | $276.48F5 | −$40,089.6 | 130 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −1,612 | $270.84F6 | −$436,594.08 | 6,518 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −3,871 | $271.67F7 | −$1,051,634.57 | 2,647 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −2,441 | $272.57F8 | −$665,343.37 | 206 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −76 | $273.56 | −$20,790.56 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 656,000 | Direct | |
| Jan 4, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 648,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $272.36 to $273.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $273.36 to $274.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $274.395 to $275.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $276.26 to $276.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $270.165 to $271.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $271.175 to $272.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $272.20 to $273.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.